2018 has started strongly for DigitalHealth.London with the highlight being the RYSE Early Stage Opportunity Fund call, which has allowed us to broaden our signposting capabilities in being able to direct digital health companies, with compelling propositions towards a source of funding with our partners RYSE Asset Management. We are still in the midst of evaluating proposals from the 109 strong applications received. The level of response signals that there is a hunger in the market place for investment at the seed level – £250K – £400K mark.
RYSE’s objective is to provide investors with capital appreciation from a diversified portfolio of investments across early stage and nascent companies over time. The offering addresses an investment or funding gap in the market which is largely overlooked by institutional and professional investors alike due to the time involved in undertaking due diligence on a number of early stage companies and their principals or founders. The opportunity enables investors to benefit from a highly diversified portfolio effect without compromising on due diligence.